Analysts Forecast $14.9M Q4 Revenue and $0.24 EPS Loss at Cellectis SA
Cellectis SA will report Q4 2025 earnings on March 20, with analysts forecasting $14.90 million in revenue and a $0.24-per-share loss. Full-year 2025 revenue estimates have risen from $55.17 million to $58.42 million, while 2026 revenue forecasts have dropped to $53.66 million.
1. Q4 2025 Earnings Preview
Cellectis SA will announce Q4 2025 earnings on March 20, with consensus revenue of $14.90 million and an expected loss of $0.24 per share.
2. Estimate Revisions Trend
Over the past 90 days, full-year 2025 revenue estimates rose from $55.17 million to $58.42 million, while 2026 forecasts declined from $69.51 million to $53.66 million and EPS projections for 2025 improved to a $0.73 deficit.
3. Prior Quarter Performance
In Q3 2025, the company reported revenue of $32.37 million versus analyst estimates of $6.01 million, and posted EPS of $0.01 compared with an estimate of -$0.24, representing beats of 438.6% and 103.7%, respectively.
4. Analyst Price Targets and Recommendations
One analyst sets a one-year price target of $6.55, implying 112.6% upside from the current level, while the estimated fair value sits at $2.75 and the consensus brokerage rating is 1.8, signaling an "Outperform" stance.